| |
| |
|
| Insider
Information: |
Shah Jatin |
| Relationship: |
EVP, Chief Medical Off... |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
129,450 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$139,806 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
129,450 |
|
|
| Total
Value |
$139,806 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
EVP, Chief Medical Off... |
2022-02-17 |
129,450 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2022-02-17 |
4 |
S |
$12.12 |
$15,833 |
D/D |
(1,306) |
129,450 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2022-02-07 |
4 |
S |
$9.86 |
$16,805 |
D/D |
(1,704) |
130,756 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2021-07-12 |
4 |
D |
$9.73 |
$6,470 |
D/D |
(665) |
131,137 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2021-05-07 |
4 |
B |
$8.60 |
$199,992 |
D/D |
23,250 |
131,802 |
2.74 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
22,013 |
107,691 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2021-02-18 |
4 |
S |
$14.83 |
$17,590 |
D/D |
(1,186) |
51,791 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,850 |
52,977 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2021-02-11 |
4 |
S |
$15.52 |
$27,127 |
D/D |
(1,748) |
48,127 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2021-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,650 |
49,875 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2020-07-15 |
4 |
S |
$19.46 |
$11,462 |
D/D |
(589) |
43,229 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2020-07-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,413 |
43,172 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2020-02-19 |
4 |
S |
$16.48 |
$22,663 |
D/D |
(1,375) |
40,759 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical Officer |
• – – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,850 |
42,134 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Medical OfficerOffi |
• – – |
2019-07-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,625 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
